Search

LErafAON

or chemotherapy. … Phase I/II trials commenced in March 2001 and were ongoing as of June 2003.

Disufenton

Fibrinolysin

The light chain has a molecular weight of approximately 27,000 Da and contains the active center of Fibrinolysin; the heavy chain has a molecular weight of approximately 57,000 Da. … Fibrinolysin consists of two polypeptide chains, one light and one heavy, linked by a disulfide bond.

Limaprost

Prostaglandins act on a variety of cells such as vascular smooth muscle cells causing constriction or dilation, on platelets causing aggregation or disaggregation and on spinal neurons causing pain. … Prostaglandins have a wide variety of actions, including, but not limited to muscular constriction and mediation of inflammation.

Brofaromine

2,5-Dimethoxy-4-ethylthioamphetamine

2,5-Dimethoxy-4-ethylthioamphetamine (ALEPH-2) is a phenylisopropylamine derivative with alleged anxiolytic and hallucinogenic properties.

Cymarin

Pegsunercept

Pegsunercept is used for treating rheumatoid arthritis. Phase II clinical trials were completed in January 2010.

Motixafortide

[L48116] When administered alongside [filgrastim], another agent used to aid in stem cell collection, motixafortide enabled the collection of an adequate number of stem cells in ~92% of patients within … via infusion of the patient's own stem cells (i.e. an autologous transplant).

Serotonin

For temporary relief of nervousness, anxiety, mood swings, joint pains, weakness, drowsiness, itching and lethargy. Not evaluated by the FDA, homeopathic product.